Head of M&A, Strategy and Investor Relations
Sheel Gill joined medmix in May 2022 as Head of M&A, Strategy and Investor Relations. Prior to this, Sheel was a Partner in KPMG’s Deal Advisory & Strategy practice in the UK, Germany, East Africa and Switzerland, having joined KPMG in 1999. She started her career as an auditor at PwC in Kenya and the UK. Overall, Sheel has 22 years of transaction and strategy experience working closely with companies across all sectors and sizes across all geographies with the aim of assisting them to achieve their growth ambitions. Additionally, Sheel has valuation, modelling and investing insights given her various roles at KPMG and her accounting and finance background.
Sheel holds a bachelor in Accounting & Finance from University of Birmingham, UK and is a qualified UK Chartered Certified Accountant.